Serina Therapeutics (SER) Receivables (2017 - 2024)
Serina Therapeutics (SER) posted Receivables of $14000.0 for Q3 2024, down 72.55% sequentially from $51000.0 in Q2 2024, and down 98.08% YoY from $728000.0 in Q4 2023.
Serina Therapeutics (SER) Receivables (2017 - 2024) Analysis & Trends
Serina Therapeutics has reported Receivables for 8 years, with the latest figure at $14000.0 in Q3 2024.
- Quarterly Receivables fell 98.08% year-over-year to $14000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $14000.0 (down 98.08% YoY) and the FY2023 annual result came in at $554000.0, up 13750.0% from the prior year.
- Receivables eased to $14000.0 in Q3 2024 per SER's latest filing, from $51000.0 in the prior quarter.
- Over five years, Receivables peaked at $728000.0 in Q3 2023 and troughed at -$190000.0 in Q2 2023.
- A 5-year average of $105166.7 and a median of $24500.0 in 2021 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 72700.0% in 2023, down 1683.33% in 2023.
- Over 5 years, Receivables stood at $326000.0 in 2020, then plunged by 92.33% to $25000.0 in 2021, then tumbled by 84.0% to $4000.0 in 2022, then jumped by 4275.0% to $175000.0 in 2023, then plunged by 92.0% to $14000.0 in 2024.
- According to Business Quant data, Receivables over the past three periods registered $14000.0, $51000.0, and -$98000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Serina Therapeutics | 44.50 Mn | 21.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Dec 31, 2023 | 175,000.00 |
| Sep 30, 2023 | 728,000.00 |
| Jun 30, 2023 | -190,000.00 |
| Mar 31, 2023 | -80,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 11,000.00 |
| Mar 31, 2021 | 48,000.00 |
| Dec 31, 2020 | 326,000.00 |
| Sep 30, 2020 | 241,000.00 |
| Jun 30, 2020 | 235,000.00 |
| Mar 31, 2020 | 366,000.00 |
| Dec 31, 2019 | 363,000.00 |
| Sep 30, 2019 | 234,000.00 |